ASTEC — Astec LifeSciences Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeSmall CapMomentum Trap

Annual income statement for Astec LifeSciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,766	6,282	4,582	3,813	4,481
Cost of Revenue
Gross Profit	2,369	1,695	964	394	1,497
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,569	5,850	5,002	4,912	4,997
Operating Profit	1,197	431	-421	-1,099	-515
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,211	349	-617	-1,410	-810
Provision for Income Taxes
Net Income After Taxes	899	256	-469	-1,347	-809
Minority Interest
Net Income Before Extraordinary Items
Net Income	899	256	-469	-1,348	-809
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	899	256	-469	-1,348	-809
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	45.5	13.1	-23.7	-68.9	-37.2
Dividends per Share